Skip to main content

Table 1 Prevalence of components of MetS at baseline and various lengths of follow-up [n(%)]

From: Prediction of the development of metabolic syndrome by the Markov model based on a longitudinal study in Dalian City

Follow-up years
  Baseline 1 2 3 4 5
N 5881 5881 3518 2065 1346 825
Male 2476 (42.10) 2476 (42.10) 1356 (38.54) 637 (30.85) 388 (28.83) 279 (33.82)
Hypertension 740 (12.58) 901 (15.32) 576 (16.37) 361 (17.48) 296 (21.99) 221 (26.79)
Obesity 1795 (30.52) 1942 (33.02) 1135 (32.26) 653 (31.62) 431 (32.02) 293 (35.52)
Hyperglycemia 529 (9.00) 593 (10.08) 349 (9.92) 206 (9.98) 170 (12.63) 138 (16.73)
Dyslipidemia 1278 (21.73) 1316 (22.38) 782 (22.23) 431 (20.87) 276 (20.51) 189 (22.91)
MetS 249 (4.23) 431 (7.57) 256 (7.28) 158 (7.65) 136 (10.10) 110 (13.33)
  1. The interval between any two consecutive follow-up years was 1 year